Merck & Co. Inc. (MRK) recently joined forces with Bristol-Myers Squibb (BMY) to conduct a phase II study with their hepatitis C virus...(read more
Will This Drug Be The Next Hit?
Is it Time to Load Up on Some Gold?
The "Slap in the Face" Award: Shanghai Edition...
The Medicines Company (MDCO) recently received good news with the company announcing positive results on its phase III candidate, cangrelor. Cangrelor is being...(read more